The economic burden of coronary heart disease in the UK

Heart

Volumn 88, Issue 6, 2002, Pages 597-603

  Liu, Joseph L Y ^a,b   Maniadakis, N ^b   Gray, A ^b   Rayner, M ^c  

^a WOLFSON COLLEGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; AGE DISTRIBUTION; ARTICLE; CORONARY ARTERY DISEASE; COST OF ILLNESS; EMERGENCY HEALTH SERVICE; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0036899665     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.6.597     Document Type: Article

References (50)

1. British Heart Foundation. Coronary Heart Disease Statistics. London: British Heart Foundation, 1999.
2. NHS Executive. Burdens of Disease: A Discussion Document. Wetherby: Department of Health, 1996.
3. Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.
4. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000;84:95-103.
5. Griffin J. Deep Vein Thrombosis and Pulmonary Embolism. London: Office of Health Economics, 1996.
6. Guest JF, Morris A. Community acquired lower respiratory tract infections: The annual cost to the National Health Service. Br J Med Econ 1996;10:263-73.
7. McIntosh E. The cost of rheumatoid arthritis. Br J Rheumatol 1996;45:781-90.
8. Gray A, Fenn P, McGuire AJ. The cost of insulin dependent diabetes mellitus (IDDM) in England and Wales. Diabet Med 1995;12:1068-76.
9. Hart WM, Guest J. Critical limb ischaemia: The burden of illness in the UK. Br J Med Econ 1995;8:211-21.
10. Jonsson B, Bebbington BE. What price for depressions? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Pyschiatry 1994;164:665-73.
11. Drummond MF, McGuire AJ, Black NA, et al. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 1993;71:290-6.
12. Gray AM, Fenn PF. Alzheimer's disease: The burden of the illness in England. Health Trends 1993;25:31-7.
13. Wyles M. Arthritis. London: Office of Health Economics, 1992.
14. Bosanquet N, Zammit-Lucia J. Migraine: A Strategy for Treatment. Cambridge: Daniels Publishing, 1991.
15. Griffin J, Wyles M. Epilepsy: Towards Tomorrow. London: Office of Health Economics, 1991.
16. Dale S. Stroke. London: Office of Health Economics, 1989.
17. Holmes J, Madgwick T, Bates D. The costs of multiple sclerosis. Br J Med Econ 1995;8:181-93.
18. Laing W, Williams R. Diabetes: A Model for Health Care Management. London: Office of Health Economics, 1989.
19. Currie CJ, Morgan CL, Peters JR. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 1997;78:544-9.
20. Audit Commission. Dear to Our Hearts? Commissioning Services for the Treatment or Prevention of Coronary Heart Disease. London: HMSO, 1995.
21. Wells N. Coronary Heart Disease: The Need for Action. London: Office of Health Economics, 1987.
22. Office of Health Economics. Compendium of Health Statistics, 9th Ed. London: Office of Health Economics, 1995.
23. British Heart Foundation. Coronary Heart Disease Statistics: Economics Supplement. London: British Heart Foundation, 1998.
24. Office for National Statistics. Annual Abstract of Statistics 2000. London: HMSO, 2000.
25. Netten A, Dennett J, Knight J. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit (PSSRU), University of Kent, 1999.
26. Joint Health Surveys Unit. Health Survey for England 1998, Vol 1. Findings. London: HMSO, 1999.
27. McCormick A, Fleming D, Charlton J. Morbidity Statistics from General Practice: 4th National Study 1991-92. London: HMSO, 1995.
28. Department of Health. Hospital Episode Statistics, Vol 1. Finished Consultant Episodes by Diagnosis, Operation and Specialty, England 2000-2001. London: Department of Health, 2001.
29. Office for National Statistics. Key Health Statistics from General Practice. London: HMSO, 1996.
30. Campbell NC, Grimshaw JM, Ritchie LD, et al. Outpatient cardiac rehabilitation: Are the potential benefits being realised? J R Coll Physicians Lond 1996;30:514-19.
31. Gray A, Bowman GS, Thompson DR. The cost of cardiac rehabilitation services in England and Wales. J R Coll Physicians Lond 1997;31:57-61.
32. Norris RM. Fatality outside hospital from acute coronary events in three British health districts 1994-95. BMJ 1998;316:1065-70.
33. NHS Executive. Finance Manual. Wetherby: Department of Health, 1999.
34. Department of Health. NHS Trust Financial Returns Form 2 (TFR2) Specialty-Specific Costs per in Patient Day for Hospital Inpatient Care and Day Case Care. London: HMSO, 2000.
35. Department of Health. The Government's Expenditure Plans 1999-2000. London: HMSO, 1999.
36. Green H. Informal Carers: A Study Carried Out on Behalf of the Department of Health as Part of the 1985 General Household Survey. London: HMSO, 1988.
37. Office of Population Censuses and Surveys. Labour Force Survey. London: HMSO, 1996.
38. Posnett J, Jan S. Indirect cost in economic evaluation: The opportunity cost of unpaid inputs. Health Economics 1996;5:13-23.
39. Department of Employment. New Earnings Survey. London: HMSO, 1998.
40. Actuary Department. Annual Abstract of Statistics. London: HMSO, 1996.
41. Department of Social Security. Social Security Statistics 1995. London: HMSO, 1995.
42. Koopmanschap MA, Van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med 1992;34:1005-10.
43. Meerding WJ, Bonneux L, Polder JJ, et al. Demographic and epidemiological determinants of healthcare costs in Netherlands: Cost of illness study. BMJ 1998;317:111-15.
44. American Heart Association. 2000 Heart and Stroke Statistical Update. Dallas: American Heart Association, 1999.
45. Sagmeister M, Gessner U, Oggier W, et al. An economic analysis of ischaemic heart disease. Eur Heart J 1997;18:1102-9.
46. Heart and Stroke Foundation of Canada. The Changing Face of Heart Disease and Stroke in Canada 2000. Ottawa: Heart and Stroke Foundation of Canada, 1999.
47. Bruckenberger E. Health Report for Germany 1998. Hannover: Niedersächsisches Sozialministerium, 1999.
48. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, Vol 1. Global Burden of Disease and Injury Series. Boston: Harvard University Press, 1996.
49. Mehrez A, Gafni A. Healthy-years equivalent versus quality-adjusted life years: In pursuit of progress. Med Decis Making 1993;13:287-92.
50. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340:1881-7.